Stay updated on Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Sign up to get notified when there's something new on the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.

Latest updates to the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page
- Check6 days agoChange DetectedThe page's revision label updated to v3.5.4 from v3.5.3, signaling a minor update to the page version.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page revision label changed from v3.5.2 to v3.5.3, signaling a new version of the page on ClinicalTrials.gov. This update represents an internal revision of the page metadata and does not modify the study data or what users see.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check56 days agoChange DetectedNapoli, Campania, Italy, 80131 was replaced by Naples, Campania, Italy, 80131 in the Locations.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded expanded eligibility criteria and a broader, updated list of study sites for the RMS trial, including a new site in Joinville, Brazil (89202-190), and revised study design and outcome measures.SummaryDifference1%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3, a metadata/versioning change that does not alter study details.SummaryDifference0.0%

Stay in the know with updates to Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Fenebrutinib vs Teriflunomide in RMS Clinical Trial page.